Oncology Pharma, Inc. (ONPH)
0.10
0.00 (0.00%)
USD |
OTCM |
Apr 02, 16:00
Oncology Pharma Enterprise Value : 0.0744M for April 2, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| ACADIA Pharmaceuticals, Inc. | 3.017B |
| Alnylam Pharmaceuticals, Inc. | 42.35B |
| Savara, Inc. | 932.11M |
| BioMarin Pharmaceutical, Inc. | 9.756B |
| Imunon, Inc. | -0.9398M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -0.0008M |
| Total Expenses (Quarterly) | 0.0008M |
| Earnings Yield | -155.6% |
| Normalized Earnings Yield | -155.60 |